Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease.
Bacteroides ovatus
Bifidobacterium adolescentis
Dysbiosis
Faecalibacterium prausnitzii
Ruminococcus gnavus
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 10 2019
09 10 2019
Historique:
received:
17
09
2019
revised:
07
10
2019
accepted:
08
10
2019
entrez:
12
10
2019
pubmed:
12
10
2019
medline:
12
10
2019
Statut:
epublish
Résumé
The response to treatment with biologic drugs, in patients with Crohn's disease, could be associated with changes in gut microbiota composition. The aim of our study was to analyse the modification of microbiota during adalimumab therapy in patients with Crohn's disease. We performed a prospective study in patients with Crohn's disease analysing gut microbiota before start of adalimumab therapy (T0) and after six months of therapy (T1). Among the 20 included patients, the phylum
Identifiants
pubmed: 31601034
pii: jcm8101646
doi: 10.3390/jcm8101646
pmc: PMC6832711
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Emerg Infect Dis. 2018 Sep;24(9):1683-1690
pubmed: 30124405
J Crohns Colitis. 2011 Aug;5(4):324-31
pubmed: 21683302
MBio. 2018 Mar 13;9(2):
pubmed: 29535202
Immune Netw. 2017 Feb;17(1):1-12
pubmed: 28261015
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):47-58
pubmed: 23768552
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
Clin Exp Gastroenterol. 2019 Jul 19;12:321-329
pubmed: 31410046
APMIS. 2017 Jan;125(1):3-10
pubmed: 27704622
J Crohns Colitis. 2018 Feb 28;12(3):337-346
pubmed: 29194468
Ann Oncol. 2017 Jun 1;28(6):1368-1379
pubmed: 28368458
Front Microbiol. 2016 Aug 17;7:1272
pubmed: 27582735
Clin Chem. 2009 Apr;55(4):641-58
pubmed: 19246620
Int Immunol. 2015 Jan;27(1):55-62
pubmed: 25411043
Cell Host Microbe. 2017 Aug 9;22(2):247
pubmed: 28799909
Front Microbiol. 2018 Aug 14;9:1835
pubmed: 30154767
Clin Diagn Lab Immunol. 2002 Jan;9(1):54-9
pubmed: 11777829
Inflamm Bowel Dis. 2014 Jun;20(6):978-86
pubmed: 24788220
J Crohns Colitis. 2015 Oct;9(10):899-906
pubmed: 26142465
Front Microbiol. 2016 Aug 19;7:1204
pubmed: 27594848
PLoS One. 2012;7(6):e39242
pubmed: 22768065
Elife. 2019 Jan 22;8:
pubmed: 30666959
Pathogens. 2019 Aug 13;8(3):null
pubmed: 31412603
Cell Host Microbe. 2017 May 10;21(5):603-610.e3
pubmed: 28494241
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Clin Transl Gastroenterol. 2018 Jan 18;9(1):e132
pubmed: 29345635
Gut Microbes. 2016;7(1):58-62
pubmed: 26939853
Gut. 2011 May;60(5):631-7
pubmed: 21209126
FEMS Microbiol Lett. 2015 Nov;362(21):null
pubmed: 26420851
J Crohns Colitis. 2016 Aug;10(8):943-52
pubmed: 26896085
J Mol Med (Berl). 2018 Sep;96(9):861-871
pubmed: 29987405
Front Med (Lausanne). 2018 Nov 20;5:304
pubmed: 30525037